Cost of Illness in Inflammatory Bowel Disease
- 1 August 2017
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 62 (9) , 2318-2326
Abstract
Frequent relapses sometimes necessitating hospitalization and the absence of pharmacological cure contribute to substantial healthcare costs in inflammatory bowel diseases (IBDs). The costs of health care in Indian patients with IBD are unknown.Keywords
This publication has 50 references indexed in Scilit:
- Unit Cost of Medical Services at Different Hospitals in IndiaPLOS ONE, 2013
- Differentiation of Crohn’s disease from intestinal tuberculosis in India in 2010World Journal of Gastroenterology, 2011
- Natural history of Crohn's disease in a population-based cohort from Cardiff (1986–2003): a study of changes in medical treatment and surgical resection ratesGut, 2010
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2009
- Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and AdultsGastroenterology, 2008
- Medication Non-adherence is Associated with Increased Medical Health Care CostsDigestive Diseases and Sciences, 2007
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2005
- Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective studyGut, 2004
- A Practical Guide for Calculating Indirect Costs of DiseasePharmacoEconomics, 1996
- A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITYThe Lancet, 1980